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Abstract
Background: Bacterial colonization is hypothesized to play a pathogenic role in the non-healing state of chronic wounds.
We characterized wound bacteria from a cohort of chronic wound patients using a 16S rRNA gene-based pyrosequencing
approach and assessed the impact of diabetes and antibiotics on chronic wound microbiota.
Methodology/Principal Findings: We prospectively enrolled 24 patients at a referral wound center in Baltimore, MD;
sampled patients’ wounds by curette; cultured samples under aerobic and anaerobic conditions; and pyrosequenced the
16S rRNA V3 hypervariable region. The 16S rRNA gene-based analyses revealed an average of 10 different bacterial families
in wounds—approximately 4 times more than estimated by culture-based analyses. Fastidious anaerobic bacteria belonging
to the Clostridiales family XI were among the most prevalent bacteria identified exclusively by 16S rRNA gene-based
analyses. Community-scale analyses showed that wound microbiota from antibiotic treated patients were significantly
different from untreated patients (p=0.007) and were characterized by increased Pseudomonadaceae abundance. These
analyses also revealed that antibiotic use was associated with decreased Streptococcaceae among diabetics and that
Streptococcaceae was more abundant among diabetics as compared to non-diabetics.
Conclusions/Significance: The 16S rRNA gene-based analyses revealed complex bacterial communities including anaerobic
bacteria that may play causative roles in the non-healing state of some chronic wounds. Our data suggest that antimicrobial
therapy alters community structure—reducing some bacteria while selecting for others.
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Introduction
Chronic wounds cause substantial morbidity and economic
burden that is borne disproportionately by diabetic, geriatric, and
immobilized patients [1]. Generally associated with venous,
arterial, or metabolic abnormalities [2], more than 90% of the
chronic wounds fall into three categories: diabetic ulcers, venous
ulcers, and pressure ulcers [3]. Four processes have been
hypothesized to be the underlying cause in chronic wounds: 1)
local tissue hypoxia, 2) repetitive ischemia-reperfusion injury, 3)
altered cellular and systemic stress response, and 4) bacterial
colonization [3]. Among these, bacterial colonization is of
particular interest to clinicians for its association with chronic
wound infections and as targets for novel wound therapies.
Although bacterial colonization occurs in all chronic wounds,
the differentiation between wound colonization and invasive infection
is not well defined. The hypothesized impact of bacterial
colonization on wound healing ranges from detrimental to
beneficial depending on the colonizing bacterial species and
relative load [4]. Wound colonization is typically polymicrobial
in nature (i.e., consisting of multiple bacterial species) [5]; thus,
broad-spectrum antibiotics may modify, but not eliminate
bacterial colonization.
Clinicians routinely use antibiotics for chronic wound care, but
their optimal use and benefit remain unclear [6]. Systematic
reviews have found little evidence for the benefit of antibiotic
therapy on wound healing [7,8]. Yet, patients with chronic
wounds continue to receive more antibiotic therapy than age- and
sex-matched non-wound patients [9], even as antibiotic-resistant
organisms such as methicillin-resistant Staphylococcus aureus and
antibiotic-resistant Pseudomonas are becoming more prevalent in
wounds [10]. Assessment of the impact of antibiotic use in chronic
PLoS ONE | www.plosone.org 1 July 2009 | Volume 4 | Issue 7 | e6462wounds will be crucial to establishing an effective, evidence-based
regimen and to minimize inappropriate antibiotic use.
Traditionally, wound microbiota has been defined using
culture-based methods; however, these methods are insufficient
for characterizing complex polymicrobial communities, since
many microbes cannot be cultured. There is an increasing
number of chronic conditions and diseases associated with non-
culturable or fastidious bacteria including bacterial vaginosis [11];
Whipple’s disease [12]; and reactive arthritis [13]. Thus, it is
critical to better define the role of fastidious and non-culturable
bacteria in chronic wounds. Advanced molecular-based tech-
niques, such as 16S rRNA gene-based pyrosequencing, can be
used to characterize complex bacterial communities independent
of culture-based enrichment. Preliminary 16S rRNA gene-based
surveys of bacterial species associated with chronic wounds have
found many putative wound colonizers that were not detected
using standard culture-based methods and have revealed previ-
ously undescribed levels of bacterial diversity in chronic wounds
[14–16]. Yet, these studies were mostly descriptive due to inherent
limitations of standard statistical analyses against large, non-
parametric community datasets. By applying community ecolog-
ical analyses to evaluate the correlation between host and clinical
factors and the chronic wound bacterial microbiota, it is possible
to explore the associations between non-culturable bacteria with
wound pathogenesis, chronicity, and infection.
In this study, we used 16S rRNA gene-based pyrosequencing
analysis of the V3 region to characterize wound microbiota from a
cohort of chronic wound patients and assessed the impact of
diabetes and antibiotic therapy on bacterial communities. We
have chosen the V3 region for its demonstrated ability to resolve
bacterial taxa and produce comparable results to full-length (V1-
V9) 16S rRNA gene sequences in 98.93% and 97.99% at the
bacterial family and genus level, respectively, against human gut
microbiota data [17]. We found that wounds were colonized by a
wide-range of bacterial taxa including fastidious anaerobic
pathogens that were not observed by culture-based analyses.
Using community ecological analyses, we found evidence
supporting clinical observations that diabetics were more likely
to be colonized with Streptococcaceae and determined that recent
antibiotic use was associated with increased Pseudomonadaceae
colonization.
Results
Study Population
The demographic and clinical characteristics of the 24
participants included in the current analyses are listed in Table 1.
Thirty-two individual wound samples were collected from the 24
participants at different times during the study. Fourteen of the
wound samples were collected from patients who had been treated
with topical or systemic antibiotics within 2 weeks prior to sample
collection. The antibiotics administered prior to sample collection
are listed in Table 2. Only 3 of the 14 antibiotic-treated wound
samples were collected from participants who entered the study
without receiving systemic or topical antibiotics but were treated
during the period of observation.
Diverse Bacterial Communities Revealed by 16S rRNA
gene-based Pyrosequencing Analyses
Bacterial taxonomic richness and diversity varied greatly among
wounds examined in this study. Community richness and diversity
were presented using Rarefaction and Shannon-Weaver Index
plots, both of which provided insights into the structure and
complexity of individual wound communities.
Rarefaction plots (Figure 1A) appear as two-component
functions with a rapid increase in bacterial taxa observed until
,50 sequences are sampled; after which, a second component
Table 1. Demographic and clinical characteristics of study
participants.
Characteristics Value
Age (SD) 57.2 (15.6)
Sex
Male N=10 (41.6%)
Female N=14 (58.4%)
Race
Black N=11 (46.0%)
Caucasian N=13 (54.0%)
Primary Diagnosis (Wound Type)
Decubitus N=7
Neuropathic N=7
Venous Stasis N=3
Post-Surgical N=3
Other N=4
Diabetes Mellitus N=12 (50.0%)
Antibiotic (for wound samples, N=32)
Topical
24 h N=5 (15.6%)
Systemic
24 h N=5 (15.6%)
2 weeks N=10 (31.3%)
Any antibiotic use in past 2 weeks N=14 (43.8%)
doi:10.1371/journal.pone.0006462.t001
Table 2. Systemic antibiotics used within two weeks of
sample collection.
Wound Antibiotic
TG03 Unknown*
WS06 Keflex
WS08 Levofloxacin 750
WS10 Doxycycline
WS18 Bactrim DS, Flagyl
WS19 Clindamycin
WS20 Bactrim, Clindamycin
WS26 Levofloxacin
WS27 Clindamycin
WS30 Vantin, Flagyl
WS31 Bactrim
WS32 Bactrim DS, Flagyl
WS36 Cipro
WS38 Bactrim DS, Clindamycin
WS39 Bactrim DS
*The patient reported antibiotic use within the previous two weeks, but did not
know the name of the antibiotic.
doi:10.1371/journal.pone.0006462.t002
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PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6462Figure 1. Rarefaction and Shannon Weaver index analyses were performed for each wound specimen. (A) Rarefaction curves were used
to estimate richness (i.e., number of unique bacterial taxa) among samples. (B) Shannon Weaver Index curves were used estimate diversity (i.e., a
combined assessment of the number of unique bacterial taxa and their abundance) among samples.
doi:10.1371/journal.pone.0006462.g001
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the higher-frequency taxa that dominate the wound, while the
second component represents less-frequent taxa. In individual
wounds, the high-frequency taxa are as few as six or as great 25,
with an average of ,10. Less-frequent taxa more than double the
observed taxonomic richness but not until 250 to 300 sequences
have been analyzed.
Diversity value plots (Figure 1B) are driven entirely by the high-
frequency taxa. Similar to the rarefaction plots, the diversity values
increase until ,50 sequences have been sampled. After which, the
values stabilize with little change even when 300 sequences are
sampled. This diversity index is based upon both the number of
taxa and their frequency in the community; with numerous rare
taxa having little effect on the final value. From these data, it is
clear that 300 sequences are sufficient to estimate the bacterial
community diversity values in individual wounds.
Bacterial community structure is determined through a mixture
of high-frequency and low-frequency taxa, which are both
potentially important to wound ecology and healing. Why some
wounds have richer and more diverse communities is not apparent
in these data and could be due to host, environmental or even
stochastic processes. No trends in bacterial taxa richness or
diversity values were evident among the diabetic or antimicrobial
therapy groups (data not presented), though larger studies might
be needed to detect these effects.
Taxonomic assignments were made with a bootstrap confidence
range at $95% using the RDP Naı ¨ve Bayesian Classifier. The
level of taxonomic resolution varied among sequence types
identified in this study. While nearly all (98.8%) of the sequences
analyzed were identified to the phylum level, the proportion of
sequences successfully assigned to lower taxonomic groups
decreased to 97.5% at the class level, 95.4% at the order level,
93.2% at the family level and then precipitously to 72.6% at the
genus level. Importantly, only 53% of the Proteobacteria identified
in this study were classified to the genus level.
Compared to culture-based analyses, 16S rRNA gene-based
analyses revealed greater complexity at each taxonomic level
(Table 3), identifying 44 bacterial families among the 32 wound
samples (Figure 2). Most families were rare among samples and in
low abundance when detected, thus confirming Shannon-Weaver
Index analyses.
Only nine out of the 44 bacterial families identified by 16S
rRNA gene-based analyses were also successfully cultured in this
study (in red, Figure 2). Many of the 35 discordant families (those
detected by 16S rRNA gene-based analyses, but not by culture-
based analyses) were relatively rare among samples; however, one
family—Clostridiales family XI—was both prevalent (present in
78% of the samples) and abundant (.10% of sequences on
average in positive samples). Five genera belonging to this family
were identified among the wound samples including: Anaerococcus,
Finegoldia, Helcococcus, Parvimonas, and Peptoniphilus.
Percent agreement between 16S rRNA gene-based and culture-
based analyses averaged 71% for bacterial families that were
cultured at least once (Table 4). 16S rRNA gene-based analyses
were consistently equal to or more sensitive than culture-based
methods at detecting these nine bacterial families. Culture-
positive/pyrosequencing-negative discordance was rare; thus,
most of the disagreement was due to culture-negative/pyrose-
quencing-positive discordance.
Antibiotic Therapy and Wound Microbiota
We compared bacterial communities in wounds from patients
recently treated with antibiotics to those from untreated patients
using non-metric multidimensional scaling (nMDS) and multi-
response permutation procedure (MRPP). We further identified
the bacterial families that best distinguish the two antibiotic use
groups using Dufre ˆne & Legendre indicator analysis.
The nMDS and MRPP analyses showed significantly different
bacterial communities in patients that were untreated or treated
with antibiotic in the two weeks prior to sample collection
(Figure 3). The indicator analyses found that recent antibiotic use
was associated with increased abundance of Corynebacteriaceae,
Oxalobacteraceae, and Pseudomonadaceae.
We compared the prevalence of Corynebacteriaceae, Oxalobac-
teraceae, and Pseudomonadaceae between antibiotic use groups by
calculating the mean difference in sequence counts and performing
univariate pair-wise comparisons using a t-test statistic and Monte
Carlo-based re-sampling. We found a large proportional increase in
each of these indicator taxa in the antibiotic treated group, but the
within-group variances were also large (Table 5). Univariate
comparisons showed that Pseudomonadaceae was significantly
higher in wounds from antibiotic treated participants compared to
untreated participants. The increases in Corynebacteriaceae and
Oxalobacteraceae were not significant after the Bonferroni
correction (Table 5). To further evaluate the association between
Pseudomonadaceae and antibiotic use, we examined the prevalence
data in three participants from whom the pre- and post-antibiotic
data were available. In this small subset, we found a significant
increase in Pseudomonadaceae after antibiotic therapy (,27 fold
average increase; p=0.047).
Diabetes and Wound Microbiota
We further evaluated the association between diabetes and
chronic wound microbiota using nMDS, MRPP, indicator analysis,
and indicator prevalence as described above. The nMDS and
MRPP analyses did not reveal a significant difference between the
diabetic and non-diabetic wound microbiota on the community
level (data not shown). Indicator analysis showed that differences in
Table 3. Estimated complexity at different taxonomic levels by pyrosequencing and culture.
Pyrosequencing Culture
Taxonomiclevel Total # Among Samples Range Mean (SD) Total # Among Samples Range Mean (SD)
Phylum 6 2–5 3.3 (0.9) 4 1–4 1.9 (0.9)
Class 13 3–9 5.4 (1.4) 5 1–4 1.9 (0.9)
Order 23 3–13 7.8 (2.4) 7 1–5 2.5 (1.2)
Family 44 3–22 10.0 (3.9) 9 1–5 2.5 (1.2)
Genera 58 3–24 9.4 (4.6) 14 1–6 2.7 (1.5)
doi:10.1371/journal.pone.0006462.t003
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non-diabetic wound microbiota. Prevalence comparisons of Strep-
tococcaceae in diabetic wounds (Mean=49.83, SD=69.97) versus
non-diabetic wounds (Mean=3.92, SD=11.54) showed large
between-group and within-group variances. The difference in
Streptococcaceae prevalence between diabetic and non-diabetic
wounds was significant (p=0.015) using the Monte Carlo method.
Interaction Between Diabetes And Antibiotic Use On The
Wound Microbiota
At the genus level, indicator analysis showed that Streptococcus was a
shared indicator in antibiotic use and diabetes, with a decreased
prevalence of Streptococcus in antibiotic treated wounds compared to
untreated wounds and an increased prevalence of Streptococcus in
diabetic wounds compared to non-diabetic wounds (data not shown).
We assessed the presence of interaction between diabetes and
antibiotic use on the community-scale using nMDS and MRPP,
which revealed a significant interaction between diabetes and
antibiotic use (data not shown).
We assessed interaction between diabetes and antibiotic use in
Streptococcus colonization using multiple logistic regression. Antibi-
otic use was associated with a 41% reduction in risk of Streptococcus
colonization in diabetics (p=0.009) but no significant risk
reduction in non-diabetics (p=0.21). Additionally, in those not
recently treated with antibiotics, the diabetic wounds were 63
times more likely to be colonized with Streptococcus than the non-
diabetic wounds (OR=63, 95% CI=3.32, 1194).
Discussion
Modern molecular tools such as 16S rRNA gene-based
pyrosequencing provide powerful means to define chronic wound
bacteria. We found that chronic wounds supported complex
microbial communities comprised of a wide-range of bacterial taxa
including fastidious anaerobic bacteria that were not observed
using culture-based methods. The bacterial wound communities
characterized in this study were similar in composition to those
reported by other groups using 16S rRNA gene-based methods
[14,16]. The number and proportion of bacterial taxa ranged
greatly in individual wounds. Additional research involving
longitudinal sampling is needed to understand the dynamics of
bacterial communities in chronic wounds.
Figure 2. Heat map analysis of the 44 bacterial families detected using 16S rRNA gene-based pyrosequencing among chronic
wound samples. The families in red are those that were successfully cultured at least once during the study. The presence/absence plot on the left
shows the bacteria present in each of the wound samples. The abundance plot on the right shows the number of 16S rRNA gene pyrosequences (300
maximum) in each of the wound samples. The average copy number per positive sample for each detected bacterial family is shown on the far right.
Many rare bacterial families are only visible on the presence/absence plot on the left.
doi:10.1371/journal.pone.0006462.g002
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when determined by 16S rRNA gene-based pyrosequencing
analysis as compared to the culture-based analyses. The limitations
of culture-based methods to characterize diverse bacterial
communities from environmental and clinical samples have been
noted previously; however, many organisms missed by culture-
based methods in the current study were theoretically culturable
using conventional methods. Some of the organisms that were
missed by culture-based methods were proportionally rare and
may have been masked by more dominant organisms in the
culture media. Other organisms, such as those belonging to the
Neisseriaceae and Campylobacteriaceae families, are fastidious
and thus require special culture media that are not typically used
when culturing wounds in clinical laboratories. Obligate anaer-
obes, such as Clostridiales family XI, are particularly difficult to
grow and were not identified using culture-based methods in the
current study. Using 16S rRNA gene-based sequence analysis, we
identified bacteria from Clostridiales family XI in 25 of the 32
wounds analyzed. Five genera from this family were identified:
Anaerococcus, Finegoldia, Helcococcus, Parvimonas, and Peptoniphilus.
Complex anaerobic microbiota that include the Clostridiales
family XI have been associated with diseases such as bacterial
vaginosis [18,19], diabetic foot ulcers [16,20], necrotizing fasciitis
[21], and periodontal disease [22,23]. Thus, the data presented
here highlight the limitations of routine clinical culture to detect
potentially important fastidious pathogens.
We compared 16S rRNA gene-based pyrosequencing to culture-
based analysesfordetecting bacterialtaxa that were cultured at least
once during the study. In this analysis, we found that detection of
these culturable bacteria was consistently greater by 16S rRNA
gene-based pyrosequencing as compared to culture-based methods.
While culture-negative/pyrosequencing-positive discordant pairs
were common, culture-positive/pyrosequencing-negative discor-
dant pairs were rare. All bacterial families identified by culture-
based methods were targeted by the amplification primers used in
the current study; therefore, insufficient sampling is the most likely
explanation for the rare culture-positive/pyrosequencing-negative
discordant pairs [24]. In contrast, there are several possible
explanations for culture-negative/pyrosequencing-positive discor-
dant pairs, including: 1) Molecular detection of viable/non-culturable
bacteria.Viable/non-culturablebacteriamayinclude non-planktonic
bacteria existing in biofilms, which are common in chronic wounds;
2) Molecular detection of bacteria that were proportionately rare within the
community and masked by more dominant bacteria in culture media. This is an
expected limitation of using non-selective culture media; 3) Molecular
detection of DNA from dead (non-viable) bacteria. Detecting DNA from
dead bacteria is a common criticism of using DNA-based molecular
methods to characterize microbial communities. While we
acknowledge this potential bias, our data suggest that underestima-
tionbyculture-basedmethods is farmore likely. Strategiestoreduce
or eliminate nucleic acids from dead bacteria, such as incorporation
of DNA digestion steps prior to cell lysis, may help minimize
detection of dead bacteria. Another approach would be to perform
RNA (cDNA)-based analysis, which would identify bacteria that are
metabolically active.
The V3 hypervariable region is one of the most phylogenetically
informative regions of the 16S gene, but this study illustrates the
limitations of this region for taxonomic assignment using the RDP
classifier.Previousworkwiththe RDP classifierindicated that 83.2%
of the bacteria in the Bergey corpus could be accurately assigned to
the appropriate genus using 200 base segments of the 16S gene.
Three phyla—Firmicutes, Proteobacteria, and Actinobacteria—
were the mostcommonly misclassified [25]. The 16S sequences used
in the current study were all greater than or equal to 200 bases, with
most (89.1%) of the sequences falling into Firmicutes, Proteobac-
teria, and Actinobacteria phyla. High percentages of the Firmicutes
and Actinobacteriasequences weresuccessfully assignedtothe genus
level, 88.0% and 82.3%, respectively; however, only 53.0% of the
Proteobacteria sequences were successfully assigned to the genus
level.Mostofthe Proteobacteriasequencesbelongedtofourfamilies:
Pseudomonadaceae, Enterobacteriaceae, Oxalobacteraceae and
Neisseriaceae. Varying proportions of all four families were
successfully assigned to the genus level: 69.2%, 29.0%, 23.8% and
1.8%, respectively. A combination of sequence homoplasy and
inaccurate database assignments (i.e., falsely assigned reference
Table 4. Comparison between pyrosequencing and culture
for detecting the nine bacterial families that were successfully
cultured at least once, among all wound samples (n=32).
Pyro (2) Pyro (+) Total
Percent
Agreement
Bacteroidaceae 93.75
Culture (2)2 8 1 2 9
Culture (+)1 2 3
Total 29 3 32
Corynebacteriaceae 50.00
Culture (2)1 0 1 4 2 4
Culture (+)2 6 8
Total 12 20 32
Enterobacteriaceae 56.25
Culture (2)7 1 3 2 0
Culture (+)1 1 1 1 2
Total 8 24 32
Enterococcaceae 87.50
Culture (2)2 4 2 2 6
Culture (+)2 4 6
Total 26 6 32
Peptostreptococcaceae 78.13
Culture (2)2 5 5 3 0
Culture (+)2 0 2
Total 27 5 32
Prevotellaceae 81.25
Culture (2)2 5 3 2 8
Culture (+)3 1 4
Total 28 4 32
Pseudomonadaceae 31.25
Culture (2)1 2 1 2 2
Culture (+)1 9 1 0
Total 2 30 32
Staphylococcaceae 75.00
Culture (2)3 7 1 0
Culture (+)1 2 1 2 2
Total 4 28 32
Streptococcaceae 87.50
Culture (2)1 6 4 2 0
Culture (+)0 1 2 1 2
Total 16 16 32
doi:10.1371/journal.pone.0006462.t004
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inability to assign Proteobacteria sequences to taxonomic groups
below the family level.
Recent antibiotic use was associated with increased Pseudomo-
nadaceae colonization in the current study. A similar association
was reported previously in a study of tracheal colonization among
critically ill, intubated patients [26]. In this earlier study, daily
endotracheal aspirates were collected from patients after intuba-
tion. Bacterial communities from six of the seven patients shifted
from relatively diverse communities to Pseudomonas-dominated
Figure 3. The nMDS ordination plot comparing wound bacterial communities from antibiotic treated participants and untreated
participants. Each data point in nMDS plot represent the bacterial community identified from a single wound specimen. Comparison using MRPP
found that the antibiotic treated and untreated wound microbiota are significantly different (p=0.0069).
doi:10.1371/journal.pone.0006462.g003
Table 5. Comparison of indicator species prevalence (out of n=300 sequences for each sample) between untreated and antibiotic
treated wounds.
No Recent ABx Recent ABx
Taxonomic Group Mean (SD) Mean (SD) D Mean Empirical p-value*
Corynebacteriaceae 2.5 (3.6) 25.4 (47.1) 22.9 0.019
Oxalobacteraceae 2.9 (6.3) 9.1 (8.8) 6.2 0.020
Pseudomonadaceae 39.9 (51.0) 110.1 (75.2) 70.2 0.0046**
*The empirical p-values comparing the prevalence of indicator species between the two antibiotic use groups were generated using the Monte Carlo method. The
statistical significance level after the Bonferroni correction was 0.05/3=0.017.
**The increase in Pseudomonadaceae in the antibiotic treated group was significant at p=0.0046,0.017.
doi:10.1371/journal.pone.0006462.t005
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Pseudomonas isolates collected from these patients were susceptible
to the administered antibiotics in laboratory drug-susceptibility
tests. It was hypothesized that this paradoxical finding was the
result of differential susceptibility of Pseudomonas growing plankto-
nically versus those growing in biofilms [26]. Biofilms are thought
to be an important factor contributing to the chronicity of certain
non-healing wounds. Administration of antibiotics may select for
biofilm-producing organisms such as Pseudomonas and delay rather
than aid wound healing.
One of the limitations of our study was its observational design,
which may have resulted in selection bias. Participants were not
excluded from the study based on prior therapies and eight patients
entered the study having been treated with antibiotics within the
previous two weeks. Those participants entering the study with
recent exposure to antibiotics may have been treated in response to
pre-existing Pseudomonas colonization or infection, which may have
biased the observed association between antibiotic use and
increased Pseudomonas colonization. Three participants entered the
studywithoutrecentexposureto antibioticsand were treated during
the study. Sub-analyses of these three participants revealed a
significant increase in Pseudomonas abundance after antibiotic
treatment. These data support the hypothesis that antibiotic use
selected for increased Pseudomonas colonization, but additional
prospective studies will have to be conducted to confirm these
findings.
The 16S rRNA gene-based pyrosequencing analysis confirmed
our clinical observations indicating that diabetics were significantly
more likely to be colonized with Streptococcus. Increased Streptococcus
colonization may be an important factor contributing to the
disproportionate morbidity associated with chronic wounds among
diabetics compared to non-diabetics [27]. Antibiotic use was
associated with decreased Streptococcus colonization among diabet-
ics and thus may be a suitable therapeutic option for treating
diabetic patients with Streptococcus infections. Further studies are
needed to confirm the association between diabetes and
Streptococcus colonization and to elucidate the biological basis for
this association.
Currently, wound management is largely empirical and based
on principles of reducing bacterial load and preventing infection
[28]; however, the complexity of the wound environment makes it
likely that antimicrobial therapy could result in unintended
consequences. We have little prospective data on the microbio-
logical response to antimicrobial wound therapies. Thus, applica-
tion of 16S rRNA gene-based pyrosequencing to characterize
wound microbial communities with respect to clinical outcomes
and therapeutic interventions (particularly antibiotic treatments)
will provide critical insights into the roles of microbiota in wound
healing and the impacts of wound therapies.
Materials and Methods
Clinical specimens
The study was approved by the Johns Hopkins Institutional
Review Board. Chronic wound tissue samples were collected from
24 patients attending the Johns Hopkins Wound Center, a tertiary
wound center in Baltimore, MD. After consent and local
anesthesia, tissue was collected from the wound base with a
3 mm curette. Tissue samples were evaluated by qualitative
aerobic and anaerobic culture in a CLIA-certified laboratory as
follows: An unweighed portion of the sample was homogenized in
a 15 ml conical tube using a sterile swab. One drop of the
homogenate was plated on selective and non-selective media
including sheep blood agar, MacConkey and chocolate agar plates
and grown aerobically at 37uC for 24 hours. Columbia agar
(CNA), CDC agar, and BBE/LKV were used for the recovery of
anaerobic organisms. Plates for anaerobic assessment were
incubated in the BD anaerobic gas pouch system at 35uC for 4–
7 days.
DNA isolation from wound tissue samples
Genomic DNA was extracted from wound samples using a
bead-beating and enzymatic lysis protocol, followed by purifica-
tion using a QIAamp DNA Mini Kit (Qiagen, USA). Briefly,
frozen wound samples (10 to 100 mg) were thawed on ice then
suspended in 0.5 ml of TE50 (10 mM Tris-HCl +50 mM EDTA,
pH 8.0) solution and allowed to soak on ice for 5 min before being
vortexed. The suspension was transferred to a clean, sterile bead-
beating tube (MP Biomedicals, USA) and kept on ice. A lytic
enzyme cocktail was prepared at the time of extraction and added
to each sample as follows: 50 ml Lysozyme (450 kU ml
21), 6 ml
Mutanolysin (25 kU ml
21), 3 ml Lysostaphin (4 kU ml
21) and
41 ml TE50 for a final volume of 100 ml per sample. Samples were
digested by incubating at 37uC for 60 min in a dry heat block
before centrifugation at 1200 rpm for 1 min. To each digested
sample, 750 mg of sterile 0.1 mm diameter zirconia silica beads
(BioSpec, Products Inc. USA) were added. Bead-beating was
performed for 1 min at 2100 rpm using a BioSpec Mini-Bead
Beater-96. Following bead disruption, the tubes were centrifuged
at 1200 rpm for 1 min. A total of 200 ml of crude lysate was
transferred to a new, sterile microcentrifuge tube. To each tube,
25 ml of Proteinase K (20 mg/ml (.600 mAU/ml)) and 200 mlo f
Qiagen buffer AL were added. Samples were mixed by pulse-
vortexing for 15 sec and then incubated at 56uC for 10 min before
being centrifuged at 1200 rpm for 1 min. For each 200 ml crude
lysate, 20 ml of 3 M sodium acetate, pH 5.5 was added followed
by 200 ml of molecular grade ethanol (96–99.5%). Vortexing was
repeated for an additional 15 sec before being centrifuged at
1200 rpm for 1 min. From this point onward, purification was
carried out using the QIAmp DNA Purification from Blood or
Body Fluids (Vacuum Protocol) as per manufacturer’s instructions.
Purified genomic DNA was stored at 280uC until analysis.
Pyrosequencing library synthesis for parallel tagged
sequencing on the 454H platform
The 16S rRNA gene was amplified in two replicate 50 ml
reaction volumes. In each 50 ml reaction, 3 ml was added to 47 ml
of PCR reaction mix containing 450 nM of each broad range
forward (59-CCTACGGGAGGCAGCAGT-39) and reverse prim-
er (59-GGACTACCAGGGTATCTAATCCTGTT-39) [29], 1X
PCR buffer without MgCl2 (Invitrogen), 3 mM MgCl2, 0.2 mM
dNTP mix, 0.02 U platinum Taq (Invitrogen) using the following
touch-down PCR condition: 90 s at 95uC for initial denaturation,
30 s at 95uC for denaturation, 30 s at 64uC for annealing, 30 s at
72uC for extension with the annealing temperature decreasing by
0.3uC for each subsequent cycle for 34 cycles, followed by 5 min at
72uC for final extension. Subsequent purification, blunt-end
repair, adapter ligation, amplicon quantification and pooling,
restriction digestion, and pyrosequencing library generation were
carried according to a previously published protocol [30]. The
sample-specific, palindromic, self-hybridizing barcodes used in the
tagging reactions were generated using a self-complementary 8-nt
barcode and a rare restriction site according the same protocol.
Pyrosequencing using the 454H platform
The pooled tagged single-stranded pyrosequencing library
underwent fusion PCR and pyrosequencing using a Roche 454
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manufacturer instructions [31] at the Institute for Genome
Sciences, Genomic Resource Center.
Sequence processing
Experimental sequences were processed using a custom PERL
script, which performed the following: the script filtered the
sequence files and retained only sequences that were 200-nt or
longer. It then searched for a single barcode sequence in each
FASTA sequence, binned each sequence accordingly, and scanned
each binned sequence for the 16S forward primer sequence. The
script then trimmed off the forward primer sequence and oriented
the remaining sequence such that all sequences begin with the 59
end according to standard sense strand conventions. As a result of
our processing, sequences that were shorter than 200-nt or had
multiple barcode or primer motifs were excluded from the
analysis. We included only sequences with the forward primer
motif to ensure that the highly informative V3 region was available
for taxonomic assignment. The trimmed sequences from each
barcode bin were aligned using the NAST alignment tool (http://
greengenes.lbl.gov) [32]. After alignment, the number of sequenc-
es examined per wound sample was equilibrized to 300 sequences
by sampling randomly without replacement to facilitate subse-
quent taxa abundance analyses. Samples with fewer than 300
sequences were excluded. The cutoff of n=300 was established
based on richness (rarefaction) and diversity (Shannon-Weaver
Index) analyses using DOTUR [34], which indicated that samples
were sufficiently sampled after $300 sequences.
Taxonomic assignment
Unaligned, sequences in the equilibrated dataset were given
taxonomic assignments at a bootstrap confidence range of $95%
using the Ribosomal Database Project’s Naı ¨ve Bayesian Classifier
tool (RDP classifier) [25,35].
Rarefaction and diversity analyses
Distance matrices based on taxa abundance were generated
with the Dnadist tool of PHYLIP 3.67 using the default settings
[33]. Rarefaction and Shannon Weaver index estimations were
determined by DOTUR [34] and plotted in Microsoft Excel
(Microsoft Corp., USA).
Statistical analyses
All statistical analyses were performed using our equilibrated
dataset (n=300 sequences per sample). Community-scale multi-
variate analyses including non-metric multidimensional scaling
(nMDS), multiresponse permutation procedure (MRPP), and the
Dufre ˆne & Legendre indicator analyses were performed in R [36]
using statistical packages vegan [37], ecodist [38], BiodiversityR
[39], and labdsv [40]. The nMDS analysis is a nonparametric
ordination-based method for reducing ecological community data
complexity and identifying meaningful relationships amongst
communities, while the MRPP analysis is another nonparametric
method for testing the null hypothesis of no-difference between
communities by comparing the experimental with the expected
within-group differencethrough an iterativerandomization process.
The indicator species analysis further identifies the bacterial taxa
that are significantly unique to each environment (e.g., clinical
variables of interest). The nonparametric nature of these ecological
analysis methods is highly suitable for human bacterial community
data, which are frequently zero-rich, highly-skewed, and non-
normal and remains non-normally distributed post-data transfor-
mation. Significance level for MRPP and the Dufre ˆne & Legendre
indicator analyses were set at a=0.05.
Comparative analysis of mean indicator prevlaence between
environments (e.g. diabetics versus non-diabetics) were also
performed in R using custom codes. Briefly, using the taxa
abundance-based distance matrices, a t-statistic was calculated and
the underlying null distribution was estimated using Monte-Carlo
based resampling (n=10,000 permutations). A two-tailed empir-
ical p-value was generated by comparing the unpermuted data
with the estimated null distribution. Significance levels were set at
a=0.05 with the appropriate Bonferroni correction (a/n), with
n= number of tests performed for a single environment.
Assessment for the interaction between antibiotic use and
diabetes and the percent agreements in the comparison of 16S
rRNA gene-based and culture-based results were performed using
multivariate logistic regression and the kappa-statistic, respectively
in STATA 9 (StataCorp, USA).
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